Comparing Acute Medical Unit care versus usual ward care for adults with sudden medical illnesses
Official title: Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness in Singapore and Decrease Utilisation of Acute Care Bed-days
Run by National University Hospital, Singapore · NCT07536035 · Data updated 2026-11-12
This research will see if care in an Acute Medical Unit (AMU) leads to better outcomes than usual general-ward care for adults admitted from the emergency department with infections, falls, or COPD flare-ups.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | National University Hospital, Singapore Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | September 30, 2024 |
| Main results expected | May 31, 2026 |
| Study ends | May 31, 2026 |
| Registry record updated | April 17, 2026 |
| Trial ID | NCT07536035 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 21 or older admitted from the emergency department with acute medical illnesses such as infection, falls-related problems, or COPD exacerbation who are not pregnant and not receiving active chemotherapy.
✕Probably not a fit
People younger than 21, pregnant patients, patients on active chemotherapy, those admitted for less than 24 hours, or patients requiring acute thrombolysis or intravascular intervention for stroke are excluded and unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Investigators will compare patients admitted from the emergency department to an Acute Medical Unit (AMU) with similar patients admitted directly to general wards at a major Singapore hospital, using observational methods to match similar clinical profiles. The team will examine clinical effectiveness and cost-effectiveness outcomes such as length of stay, complications, readmissions, and resource use. Key inclusion criteria are adults 21 and older with acute medical illnesses including infection-related conditions, falls/disequilibrium, or COPD exacerbations, while people who are pregnant, on active chemotherapy, admitted under 24 hours, or requiring acute stroke interventions are excluded. The study leverages Singapore’s national healthcare setting and academic partnerships to compare how different interface care models perform in real-world practice.
Why it matters
Potential benefit: If successful, this could help hospitals deliver more timely, appropriate, and cost-effective care for adults with acute medical problems, potentially reducing complications, length of stay, and readmissions.
How similar studies have gone: Other implementations of Acute Medical Units and interface care models have shown generally favorable but variable results—often reducing length of stay and improving throughput—so effectiveness appears to depend on local implementation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * AMU inclusion criteria - admission from ED to AMU directly * Control group inclusion criteria - admission from ED to GW directly * Acute medical illnesses that includes infection-related conditions, falls-disequilibrium, and acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD). Exclusion Criteria: * Below 21 years old * Patients undergoing active chemotherapy * Patients with active pregnancy * Patients admitted less than 24 hours * Cerebrovascular disease requiring thrombolysis or intravascular intervention
Where it's running
-
National University Hospital
Singapore, Singapore Recruiting
Study contacts
- Study coordinator: John TY Soong, PhD
- Email: John_Soong@nuhs.edu.sg
- Phone: +6567727678
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
IOS-based platform to screen, diagnose, and manage COPD and asthma
This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.
-
Targeted NMES to improve breathing and leg/extra muscle strength in COPD
This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
AI-powered CT help to guide pneumonia care
A multicenter trial tests whether using a chest CT–based AI report to guide care reduces death or need for new organ support in adults with pneumonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.